Tags

Type your tag names separated by a space and hit enter

Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies.
J Neuroimmunol. 2011 Feb; 231(1-2):61-9.JN

Abstract

Immune-mediated neuropathies are a heterogeneous group of peripheral nerve disorders, which are classified by time course, clinical pattern, affected nerves and pathological features. Plasma exchange (PE) and intravenous immunoglobulins (IVIg) are mainstays in the treatment of immune-mediated neuropathies. Of all treatments currently used, IVIg has probably the widest application range in immune-mediated neuropathies and efficacy has been well documented in several randomized controlled trials for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). Beneficial effects of IVIg have also been proven for multifocal motor neuropathy (MMN). Likewise, PE is an established treatment for GBS and CIDP, whereas it is considered to be ineffective in MMN. Different mechanisms of action are sought to be responsible for the immunemodulatory effect of PE and IVIg in autoimmune disorders. Some of those might be important for immune-mediated neuropathies, while others are probably negligible. The aim of this review is to summarize the recent advances in elucidating disease-specific mechanisms of actions of PE and IVIg in the treatment of immune-mediated neuropathies.

Authors+Show Affiliations

Medical Faculty, Department of Neurology, Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, Germany. helmar.lehmann@uni-duesseldorf.deNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

21056913

Citation

Lehmann, Helmar C., and Hans-Peter Hartung. "Plasma Exchange and Intravenous Immunoglobulins: Mechanism of Action in Immune-mediated Neuropathies." Journal of Neuroimmunology, vol. 231, no. 1-2, 2011, pp. 61-9.
Lehmann HC, Hartung HP. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. J Neuroimmunol. 2011;231(1-2):61-9.
Lehmann, H. C., & Hartung, H. P. (2011). Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. Journal of Neuroimmunology, 231(1-2), 61-9. https://doi.org/10.1016/j.jneuroim.2010.09.015
Lehmann HC, Hartung HP. Plasma Exchange and Intravenous Immunoglobulins: Mechanism of Action in Immune-mediated Neuropathies. J Neuroimmunol. 2011;231(1-2):61-9. PubMed PMID: 21056913.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. AU - Lehmann,Helmar C, AU - Hartung,Hans-Peter, Y1 - 2010/11/05/ PY - 2010/11/9/entrez PY - 2010/11/9/pubmed PY - 2011/5/17/medline SP - 61 EP - 9 JF - Journal of neuroimmunology JO - J. Neuroimmunol. VL - 231 IS - 1-2 N2 - Immune-mediated neuropathies are a heterogeneous group of peripheral nerve disorders, which are classified by time course, clinical pattern, affected nerves and pathological features. Plasma exchange (PE) and intravenous immunoglobulins (IVIg) are mainstays in the treatment of immune-mediated neuropathies. Of all treatments currently used, IVIg has probably the widest application range in immune-mediated neuropathies and efficacy has been well documented in several randomized controlled trials for Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP). Beneficial effects of IVIg have also been proven for multifocal motor neuropathy (MMN). Likewise, PE is an established treatment for GBS and CIDP, whereas it is considered to be ineffective in MMN. Different mechanisms of action are sought to be responsible for the immunemodulatory effect of PE and IVIg in autoimmune disorders. Some of those might be important for immune-mediated neuropathies, while others are probably negligible. The aim of this review is to summarize the recent advances in elucidating disease-specific mechanisms of actions of PE and IVIg in the treatment of immune-mediated neuropathies. SN - 1872-8421 UR - https://www.unboundmedicine.com/medline/citation/21056913/Plasma_exchange_and_intravenous_immunoglobulins:_mechanism_of_action_in_immune_mediated_neuropathies_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0165-5728(10)00434-0 DB - PRIME DP - Unbound Medicine ER -